Compare · GCDT vs TMO
GCDT vs TMO
Side-by-side comparison of Green Circle Decarbonize Technology Limited (GCDT) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both GCDT and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $262.22B, about 519761.1x GCDT ($504,496).
- Over the past year, GCDT is down 99.5% and TMO is up 23.4% - TMO leads by 122.9 points.
- GCDT has been more active in the news (8 items in the past 4 weeks vs 6 for TMO).
- TMO has more recent analyst coverage (25 ratings vs 0 for GCDT).
- Company
- Green Circle Decarbonize Technology Limited
- Thermo Fisher Scientific Inc
- Price
- $0.12-2.67%
- $696.91-1.78%
- Market cap
- $504,496
- $262.22B
- 1M return
- -95.34%
- +6.82%
- 1Y return
- -99.53%
- +23.39%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- AMEX
- NYSE
- IPO
- 2026
- News (4w)
- 8
- 6
- Recent ratings
- 0
- 25
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest GCDT
- SEC Form 6-K filed by Green Circle Decarbonize Technology Limited
- Green Circle Decarbonize Technology Limited Issues Statement Regarding Unusual Market Activity
- SEC Form 6-K filed by Green Circle Decarbonize Technology Limited
- Green Circle Decarbonize Technology Signs Non-Binding Memorandum of Understanding for Proposed Partners with SANVO Fine Chemicals and Menzies Eurus Aviation for Airport Energy Efficiency
- SEC Form 6-K filed by Green Circle Decarbonize Technology Limited
- SEC Form 6-K filed by Green Circle Decarbonize Technology Limited
- Green Circle Decarbonize Technology Limited Enters into Preliminary Discussions Regarding Potential Application of Advanced Green Building Technologies at Landmark Karuizawa Resort and Villa Development in Japan
- SEC Form F-1 filed by Green Circle Decarbonize Technology Limited
- Green Circle Decarbonize Technology Planned to Enter AI Data Center Cooling Market with Proprietary Ultra-Low Energy Liquid Cooling Solutions
- SEC Form 6-K filed by Green Circle Decarbonize Technology Limited
Latest TMO
- SEC Form 4 filed by Thermo Fisher Scientific Inc
- Sr. VP and Chief HR Officer Britt Lisa P. sold $1,999,960 worth of shares (2,831 units at $706.45) (SEC Form 4)
- SEC Form 8-K filed by Thermo Fisher Scientific Inc
- SEC Form 10-Q filed by Thermo Fisher Scientific Inc
- SEC Form 8-K filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Reports Third Quarter 2026 Results
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M